The Claim
In patients with gout, increasing the dose of allopurinol and implementing a mail and phone reminder system is associated with an increase in the proportion of individuals achieving serum uric acid levels below 0.36 mmol/L from 38% to 50%.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In patients with gout, combining a higher dose of allopurinol with mail and phone reminders increases the percentage of patients who reach target uric acid levels from 38% to 50%.
See the scientific wording
In patients with gout, increasing the dose of allopurinol and implementing a mail and phone reminder system is associated with a rise in the proportion of individuals achieving serum uric acid levels below 0.36 mmol/L, from 38% to 50%, suggesting that structured patient engagement may improve long-term biochemical control in primary care settings.
Higher doses of allopurinol block the enzyme that makes uric acid, lowering its levels in the blood. Regular reminders ensure patients take the medicine every day, so the enzyme stays blocked and uric acid stays low.
What the research says
1 studyWhen doctors reminded gout patients to take their medicine and adjusted their dose as needed, more patients got their uric acid levels down to a safe range — from 38% to 50%. This shows that simple reminders and better dosing can help gout patients stay healthier.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.